Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cellsManon Lernoux, Marc Diederich|Clinical Epigenetics|2020Cited by 55